Herpes esophagitis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Herpes esophagitis | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Odynophagia, dysphagia, fever, chest pain |
| Complications | Esophageal perforation, stricture |
| Onset | Sudden |
| Duration | Variable |
| Types | N/A |
| Causes | Herpes simplex virus infection |
| Risks | Immunocompromised state, HIV/AIDS, chemotherapy, organ transplantation |
| Diagnosis | Endoscopy, biopsy, PCR |
| Differential diagnosis | Cytomegalovirus esophagitis, Candida esophagitis, gastroesophageal reflux disease |
| Prevention | N/A |
| Treatment | Antiviral drugs such as acyclovir, valacyclovir |
| Medication | Acyclovir, valacyclovir, famciclovir |
| Prognosis | N/A |
| Frequency | Rare in immunocompetent individuals |
| Deaths | N/A |
Herpes esophagitis is an acute viral infection of the esophagus caused by the herpes simplex virus (HSV), most commonly HSV-1. It is characterized by painful swallowing and inflammation of the esophageal mucosa. The condition is most frequently seen in immunocompromised individuals, but it can also occur in otherwise healthy persons.
Overview[edit]
Herpes esophagitis results from infection of the esophageal mucosa by HSV, leading to the formation of ulcers and inflammation. The infection may arise from:
- Reactivation of latent HSV infection
- Primary HSV infection involving the esophagus
- Direct spread from the oropharynx
Epidemiology[edit]
- More common in patients with weakened immune systems
- Seen in individuals with:
- HIV/AIDS
- Cancer receiving chemotherapy
- Organ transplantation
- Immunosuppressive therapy
- Can occur in healthy individuals, particularly young adults
Etiology[edit]
The primary cause is infection with:
- Herpes simplex virus type 1 (HSV-1)
- Less commonly Herpes simplex virus type 2 (HSV-2)
Transmission may occur through:
- Reactivation of latent infection
- Direct contact with infected secretions
Pathophysiology[edit]
After infection, HSV replicates within epithelial cells, leading to:
- Cell destruction
- Formation of vesicles
- Ulceration of the esophageal lining
The virus may remain dormant in nerve ganglia and reactivate under conditions of stress or immunosuppression.
Signs and symptoms[edit]
Common symptoms include:
- Odynophagia (painful swallowing)
- Dysphagia (difficulty swallowing)
- Retrosternal chest pain
- Fever
- Nausea and vomiting
- Loss of appetite
Some patients may also have:
- Oral herpes simplex lesions (cold sores)
- Sore throat
Diagnosis[edit]
Diagnosis is based on clinical suspicion and confirmatory testing.
Endoscopy[edit]
Endoscopy typically shows:
- Multiple small, shallow ulcers
- "Volcano-like" lesions with raised edges
- Lesions most commonly in the distal esophagus
Biopsy[edit]
Histological examination may reveal:
- Multinucleated giant cells
- Intranuclear inclusion bodies
- Viral cytopathic effects
Laboratory tests[edit]
- Polymerase chain reaction (PCR) for HSV DNA
- Viral culture (less commonly used)
Differential diagnosis[edit]
Conditions to consider include:
- Candida esophagitis
- Cytomegalovirus esophagitis
- Reflux esophagitis
- Pill esophagitis
- Eosinophilic esophagitis
Treatment[edit]
Treatment depends on the immune status of the patient.
Antiviral therapy[edit]
First-line medications include:
These drugs inhibit viral replication and shorten the course of illness.
Supportive care[edit]
- Adequate hydration
- Pain control
- Nutritional support
Severe cases[edit]
Hospitalization may be required for:
- Severe pain
- Inability to swallow
- Complications
Prognosis[edit]
- Generally favorable in immunocompetent individuals
- Symptoms usually resolve within 1–2 weeks
- Immunocompromised patients may have prolonged or recurrent disease
Complications[edit]
Although uncommon, complications may include:
- Esophageal ulceration
- Bleeding
- Perforation (rare)
- Secondary infections
Prevention[edit]
Preventive strategies include:
- Managing underlying immunosuppression
- Antiviral prophylaxis in high-risk patients
- Avoiding exposure to active HSV infections
See also[edit]
- Herpes simplex virus
- Esophagitis
- Candida esophagitis
- Cytomegalovirus infection
- Gastroenterology
- Infectious disease
External links[edit]
- Centers for Disease Control and Prevention – Herpes
- National Institute of Diabetes and Digestive and Kidney Diseases
| Health science - Medicine - Gastroenterology - edit |
|---|
| Diseases of the esophagus - stomach |
| Halitosis | Nausea | Vomiting | GERD | Achalasia | Esophageal cancer | Esophageal varices | Peptic ulcer | Abdominal pain | Stomach cancer | Functional dyspepsia | Gastroparesis |
| Diseases of the liver - pancreas - gallbladder - biliary tree |
| Hepatitis | Cirrhosis | NASH | PBC | PSC | Budd-Chiari | Hepatocellular carcinoma | Acute pancreatitis | Chronic pancreatitis | Pancreatic cancer | Gallstones | Cholecystitis |
| Diseases of the small intestine |
| Peptic ulcer | Intussusception | Malabsorption (e.g. Coeliac, lactose intolerance, fructose malabsorption, Whipple's) | Lymphoma |
| Diseases of the colon |
| Diarrhea | Appendicitis | Diverticulitis | Diverticulosis | IBD (Crohn's, Ulcerative colitis) | IBS | Constipation | Colorectal cancer | Hirschsprung's | Pseudomembranous colitis |